$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Coronary artery disease is a predictor of major adverse cardiovascular events. CAC on CT scans provides objective evidence of coronary artery disease and may identify previously undiagnosed patients. In addition, CAC has a significant prognostic value. Specifically, the absence of CAC on gated cardiac CT scans identifies a patient population that has a low risk for subsequent cardiovascular events in many different subsets of patients, including patients presenting with cardiac symptoms, as well as asymptomatic patients1,2. With ~70 million CT scans performed in the United States and the usage rising, and approximately 11 - 12 million of those scans being CT scans of the chest, the potential for identification of CAC in a large number of patients remains high3. However, the majority of the CT scans of the chest performed in that analysis are not dedicated cardiac CT scans. Dedicated cardiac CT scans have standardized slice thickness, acquisition protocols, electrocardiographic (ECG) gating to minimize cardiac motion, and reconstruction protocols. There is also a standardized quantitation for gated cardiac CT scans using the Agatston score. The Agatston scoring system has been well validated and associated with clinical outcomes1,2.
CAC can be readily identified on these non-gated CT scans but is often overlooked4. Good correlation has been demonstrated between CAC identified on non-gated CT scans and Agatston scores obtained from gated CT scans (> 90% in pooled analysis)5,6,7,8,9,10. In non-gated CT scans, the presence of CAC has been associated with worse clinical outcomes; whereas, the absence is linked to morbidity and mortality benefits10,11,12,13,14,15.
While different studies have looked at the prognosis of CAC on non-gated studies, there has been limited published data on how best to identify CAC. There have been attempts to identify an automated approach to the identification of CAC in low-dose CT chests scans done for lung cancer screening purposes; however, the translation of this to other study protocols is extremely limited16. The introduction of differential CT scanners, protocols, and contrast (both timing and amount) limits the application of this automated approach. Attempts by the Society of Cardiovascular Computed Tomography and the Society of Thoracic Radiology to promote the standard reporting of CAC on all CT chests have been met with mixed results17. While offering a general framework in this guideline document, the specifics of the identification of coronary calcification, especially for providers who do not routinely visualize coronary anatomy, are limited. Also, strategies specific to abdominal CT scans, contrasted studies, and adjudicating challenging cases are not addressed. Many studies publish their own inter- and intra-observer reproducibility for the protocol they used; however, there is not a standard approach used across different studies.
The ability to consistently and reliably identify CAC on these non-gated CT scans allows for the retrospective and prospective observational investigation of CAC in predicting cardiovascular outcomes in many different conditions. However, there needs to be a standard approach taken to identifying CAC on non-gated CT scans to ensure the reproducibility of the results, as well as a consistency in training to help in clinical practice.